DAFTAR PUSTAKA

1. Yu-Wai-Man P, Griffiths PG, Hudson G, Chinnery PF. Inheritedmitochondrial optic neuropathies. J Med Genet[Internet]. 2009[cited 2012Aug 28]; 46:145–58. Available from :http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643051/

2. Harding AE, Sweeney MG, Govan GG, Riordan-Eva P. Pedigree analysis inLeber hereditary optic neuropathy families with apathogenic mtDNAmutation. Am J Hum Genet [Internet]. 1995 [cited 2012 Aug 13];57(1):77–86. Available from:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1801226/pdf/ajhg00033-0104.pdf

3. Newman NJ, Biousse V. Hereditary optic neuropathies. Eye. 2004;18(11):1144–1160.

4. Mackey DA, Oostra RJ, Rosenberg T, Nikoskelainen E, Bronte-Stewart J,Poulton J, et al. Primary pathogenic mtDNA mutations in multigenerationpedigrees with Leber hereditary optic neuropathy. American journal of humangenetics[Internet]. 1996 [cited 2012 Aug 13] ;59(2):481. Available from:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1914749/pdf/ajhg00021-0208.pdf

5. Johns DR, Colby KA, editors. Treatment of Leber's hereditary opticneuropathy: theory to practice. Seminars in Ophthalmology; 2002: InformaUK Ltd UK.

6. Nishioka T, Tasaki M, Soemantri A, Dyat M, Susanto J, Tamam M, et al.Leber's hereditary optic neuropathy with 14484 mutation in Central Java,Indonesia. Journal of human genetics[Internet]. 2003 [cited 2012 Aug 2013];48(7):385-9. Available from:http://www.springerlink.com/index/64JQE9F1JHWKX79Q.pdf

7. Nikoskelainen E, Marttila R, Huoponen K, Juvonen V, Lamminen T,Sonninen P, et al. Leber's" plus": neurological abnormalities in patients withLeber's hereditary optic neuropathy. Journal of Neurology, Neurosurgery &Psychiatry[Internet]. 1995[cited 2012 Aug 13]; 59(2):160-4. Available from :http://jnnp.bmj.com/content/59/2/160.full.pdf

8. Savini G, Barboni P, Valentino ML, Montagna P, Cortelli P, De Negri AM, etal. Retinal nerve fiber layer evaluation by optical coherence tomography inunaffected carriers with Leber's hereditary optic neuropathy mutations.Ophthalmology[Internet]. 2005[Cited 2012 Aug 13]; 112(1):127-31.Available from:http://www.sciencedirect.com/science/article/pii/S0161642004016574

9. Man PY, Turnbull DM, Chinnery PF. Leber hereditary optic neuropathy. JMed Genet. 2002;39:162–9.

10. Higginson IJ, Carr AJ. Using quality of life measures in the clinical setting.Bmj[Internet]. 2001[cited 2012 Aug 13]; 322(7297):1297-300. Availablefrom: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1120388/

11. Yanagisawa M, Kato S, Kobayashi M, Watanabe M, Ochiai M. Relationshipbetween vision-related quality of life and different types of existing visualfields in Japanese patients. International Ophthalmology. 2012:1-7.

12. Joan Stelmack O. QUALITY OF LIFE ASSESSMENT AND RESEARCHON HEALTH CARE OUTCOMES. Journal Article, Available from:webpages.charter.net

13. Kirkman MA, Korsten A, Leonhardt M, Dimitriadis K, Ireneaus F, KlopstockT, et al. Quality of life in patients with leber hereditary optic neuropathy.Investigative ophthalmology & visual science[Internet]. 2009[cited 2012 Aug13]; 50(7):3112-5. Available from:http://www.iovs.org/content/50/7/3112.full

14. Suzukamo Y, Oshika T, Yuzawa M, Tokuda Y, Tomidokoro A, Oki K, et al.Psychometric properties of the 25-item national eye institute visual functionquestionnaire (NEI VFQ-25), japanese version. Health and quality of lifeoutcomes. 2005;3(1):65. Available from:http://www.biomedcentral.com/1477-7525/3/65

15. Deramo VA, Cox TA, Syed AB, Lee PP, Fekrat S. Vision-related quality oflife in people with central retinal vein occlusion using the 25-item NationalEye Institute Visual Function Questionnaire. Archives of Ophthalmology.2003;121(9):1297.

16. McKean-Cowdin R, Wang Y, Wu J, Azen SP, Varma R. Impact of visualfield loss on health-related quality of life in glaucoma: the Los Angeles LatinoEye Study. Ophthalmology. 2008;115(6):941-8.

17. Riordan-Eva P, Whitcher J. Vaughan & Asbury's general ophthalmology:Wiley Online Library; 2008.

18. Zhang J, Richard M. Rubin and Narsing A. Rao. Duanes Ophthalmology:Anatomy and Embryology of the Optic Nerve [Internet] . 2006. e-bookavailable from:http://www.oculist.net/downaton502/prof/ebook/duanes/pages/v7/v7c025.html#r3

19. Hayreh SS: Anatomy and physiology of the optic nerve head. Trans Am AcadOphthalmol Otolaryngol. 1974. 78:240

10.http://webeye.ophth.uiowa.edu/component/content/article/118-aionpart2?start=1

21. Kujoth G, Hiona A, Pugh T, Someya S, Panzer K, Wohlgemuth S, et al.Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalianaging. Science[Internet]. 2005[Cited 2012 Dec] ;309(5733):481. Availablef r o m :http://newburyparkhighschool.net/lockwood/IBBio/HANDOUTS/ARTICLE-mtDNA_Aging.pdf

22. http://www.sciencedirect.com/science/article/pii/B978070202983700043723. Kirkman MA, Yu-Wai-Man P, Korsten A, Leonhardt M, Dimitriadis K, De

Coo IF, et al. Gene–environment interactions in Leber hereditary optic

neuropathy. Brain[Internet]. 2009[cited 2012 Dec 7];132(9):2317-26.Available from: http://brain.oxfordjournals.org/content/132/9/2317.long

24. Man PYW, Turnbull D, Chinnery P. Leber hereditary optic neuropathy.Journal of medical genetics[Internet]. 2002 [Last revised April 19, 2012, cited2012 Aug 13];39(3):162-9. Available from:http://jmg.bmj.com/content/39/3/162.full

25. Newman NJ, Biousse V, Newman SA, Bhatti MT, Hamilton SR, Farris BK,et al. Progression of visual field defects in leber hereditary optic neuropathy:experience of the LHON treatment trial. American journal of ophthalmology.2006;141(6):1061-7. e1. Available from:http://www.ajo.com/article/s0002-9394(06)00018-3/abstract

26. Johns DR, Neufeld M. Pitfalls in the molecular genetic diagnosis of Leberhereditary optic neuropathy (LHON). American journal of human genetics.1993;53(4):916.

27. Chalmers R, Schapira A. Clinical, biochemical and molecular genetic featuresof Leber's hereditary optic neuropathy. Biochimica et biophysica acta.1999;1410(2):147.

28. Singh G, Lott MT, Wallace DC. A mitochondrial DNA mutation as a cause ofLeber's hereditary optic neuropathy. New England Journal of Medicine.1989;320(20):1300-5.

29. Brown MD, Voljavec AS, Lott M, Torroni A, Yang CC, Wallace DC.Mitochondrial DNA complex I and III mutations associated with Leber'shereditary optic neuropathy. Genetics. 1992;130(1):163-73.

30. Vilkki J, Savontaus M, Nikoskelainen E. Genetic heterogeneity in Leberhereditary optic neuroretinopathy revealed by mitochondrial DNApolymorphism. American journal of human genetics. 1989;45(2):206.

31. Greaves LC, Reeve AK, Taylor RW, Turnbull DM. Mitochondrial DNA anddisease. The Journal of pathology[Internet]. 2012[cited 2012 Dec]; 226: 275.Available from :http://www.muskelkrank.ch/downloads/forschung/Turnbull.%20Review.pdf

32. Mariotti C, Tiranti V, Carrara F, Dallapiccola B, DiDonato S, Zeviani M.Defective respiratory capacity and mitochondrial protein synthesis intransformant cybrids harboring the tRNA (Leu (UUR)) mutation associatedwith maternally inherited myopathy and cardiomyopathy. Journal of ClinicalInvestigation[Internet]. 1994[cited 2012 Dec];93(3):1102. Available from:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC294050/pdf/jcinvest00032-0192.pdf

33. Taylor RW, Turnbull DM. Mitochondrial DNA mutations in human disease.Nature Reviews Genetics. 2005;6(5):389-402.

34. Campbell. Biologi,Edisi kelima Jilid I,164-165,197. Jakarta: Erlangga; 2002.35. Murray, Robert K, Granner Daryl K, Rodwell Victor W. Biokimia Harper

Ed.25, Jakarta:Penerbit Buku Kedokteran EGC;2006.36. Irwin MH, Parameshwaran, Pinkert CA. Mouse models of mitochondrial

complex I dysfunction. The International Journal of Biochemistry & Cell

Biology[Internet].2013[cited january 2013]. 45(1):34-40. Available from:http://www.sciencedirect.com/science/article/pii/S1357272512002877

37. Danielson SR, Wong A, Carelli V, Martinuzzi A, Schapira AHV, CortopassiGA. Cells bearing mutations causing Leber's hereditary optic neuropathy aresensitized to Fas-Induced apoptosis. Journal of BiologicalChemistry[Internet]. 2002[Cited 2013 Jan 16];277(8):5810-5. Available from:http://www.jbc.org/content/277/8/5810.long

38. Venna N. Mitochondrial neurological diseases: a clinician’s perspective.Neurology India. 2004;52(3):305.

39. Wallace DC. Mitochondrial defects in cardiomyopathy and neuromusculardisease. American heart journal. 2000;139(2):s70-s85.

40. Nikoskelainen E, Marttila R, Huoponen K, Juvonen V, Lamminen T,Sonninen P, et al. Leber's" plus": neurological abnormalities in patients withLeber's hereditary optic neuropathy. Journal of Neurology, Neurosurgery &Psychiatry[Internet]. 1995[cited 2012 Aug];59(2):160-4. Available from:http://jnnp.bmj.com/content/59/2/160.full.pdf

41. Quiros P, Torres R, Salomao S, Berezovsky A, Carelli V, Sherman J, et al.Colour vision defects in asymptomatic carriers of the Leber’s hereditary opticneuropathy (LHON) mtDNA 11778 mutation from a large Brazilian LHONpedigree: a case-control study. British journal of ophthalmology[Internet].2006[cited 2012 Sep 14];90(2):150-3. Available from:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1860163/

42. Yen MY, Wang AG, Wei YH. Leber's hereditary optic neuropathy: amultifactorial disease. Progress in retinal and eye research.2006;25(4):381-96.

43. WHOQOL: Measuring Quality of Life. 1997. Available from: URL:http//www.int/mental_health/media/68.pdf

44. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life.Annals of internal medicine. 1993;118(8):622.

45. Halim MS. QUALITY OF LIFE AND BREAST CANCER: FROMRESEARCH TO ‘FUTURE’ISSUES. Jurnal psikologi. 2004;12:1-11. Available from: http://isjd.pdii.lipi.go.id/admin/jurnal/13104112.pdf

46. Mangione CM, Berry S, Spritzer K, Janz NK, Klein R, Owsley C, et al.Identifying the content area for the 51-item National Eye Institute VisualFunction Questionnaire: results from focus groups with visually impairedpersons. Archives of Ophthalmology[Internet]. 1998[cited 2012 Feb6];116(2):227. Available from:http://archopht.ama-assn.org/cgi/reprint/116/2/227.pdf

47. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD.Development of the 25-item national eye institute visual functionquestionnaire. Archives of Ophthalmology[Internet]. 2001[cited 2012 Feb6];119(7):1050. Available from:http://archopht.ama-assn.org/cgi/reprint/119/7/1050.pdf

48. Rossi GC, Milano G, Tinelli C: The Italian version of the 25-item NationalEye Institute Visual Function Questionnaire: translation, validity, andreliability. J Glaucoma 2003, 12:213-220

49. Nordmann JP, Viala M, Sullivan K, Arnould B, Berdeaux G: PsychometricValidation of the National Eye Institute Visual Function Questionnaire – 25(NEI VFQ-25) French version: in a population of patients treated for ocularhypertension and glaucoma. Pharmacoeconomics 2004; 22:197-206.

50. Broman AT, Munoz B, West SK, Rodriguez J, Sanchez R, Snyder R, KleinR: Psychometric properties of the 25-item NEI-VFQ in a Hispanic population:Proyecto VER. Invest Ophthalmol Vis Sci 2001; 42:606-613

51. Franke GH, Esser J, Reimer J, Maehner N: Vision targeted quality of lifeunder different degrees of visual impairment. Revista Portuguesa dePsicossomática 2002; 4:39-49.

52. Suzukamo Y, Oshika T, Yuzawa M, Tokuda Y, Tomidokoro A, Oki K, et al.Psychometric properties of the 25-item national eye institute visual functionquestionnaire (NEI VFQ-25), japanese version. Health and quality of lifeoutcomes. 2005;3(1):65.

53. COMS Quality of Life Study Group: Quality of life assessment in thecollaborative ocular melanoma study: design and methods. COMS-QOLSReport No. 1. Ophthalmic Epidemiol 1999;6:5-17.

54. Cole SR, Beck RW, Moke PS, Gal RL, Long DT. The National Eye InstituteVisual Function Questionnaire: experience of the ONTT. Optic NeuritisTreatment Trial. Invest Ophthalmol Vis Sci 2000; 41:1017-1021.

55. Miskala PH, Bressler NM, Meinert CL. Relative contributions of reducedvision and general health to NEI-VFQ scores in patients with neovascularage-related macular degeneration. Arch Ophthalmol 2004; 122:758-766.

56. O’Conner M, TenHove MW. Health-Related Quality of Life for personaffected by Leber’s Hereditary Optic Neuropathy. NANOS 2000: PosterPresentations. Available from :

http://content.lib.utah.edu/cdm/ref/collection/ehsl-nam/id/3866

57. Ziaei H, Katibeh M, Sabbaghi M, Yaseri M, Eskandari A. Vision RelatedQuality of Life in Myopia; Photorefractive Keratectomy versus NonsurgicalOptical Correction. Journal of ophthalmic & vision research. 2012;7(3):219.

58. Klein R, Moss SE, Klein BK, Gutierrez P, Mangione CM. The NEI-VFQ-25in People With Long-term Type 1 Diabetes Mellitus: The WisconsinEpidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol.2001;119(5):733-740. doi:10.1001/archopht.119.5.733. Available from :http://archopht.jamanetwork.com/article.aspx?articleid=266360

59. Hirneiß C, Schmid-Tannwald C, Kernt M, Kampik A, Neubauer AS. The NEIVFQ-25 vision-related quality of life and prevalence of eye disease in aworking population. Graefe's Archive for Clinical and ExperimentalOphthalmology. 2010;248(1):85-92.

60. Orr P, Rentz AM, Margolis MK, Revicki DA, Dolan CM, Colman S, et al.Validation of the National Eye Institute Visual Function Questionnaire-25(NEI VFQ-25) in age-related macular degeneration. Investigativeophthalmology & visual science. 2011;52(6):3354-9. Available from :http://www.iovs.org/content/52/6/3354.long

61. Wu S-Y, Hennis A, Nemesure B, Leske MC. Impact of glaucoma, lensopacities, and cataract surgery on visual functioning and related quality oflife: the Barbados Eye Studies. Investigative ophthalmology & visual science.2008;49(4):1333-8.

Available from : http://www.iovs.org/content/49/4/1333.long

62. Jampel HD, Schwartz A, Pollack I, Abrams D, Weiss H, Miller R. Glaucomapatients' assessment of their visual function and quality of life. Journal ofglaucoma. 2002;11(2):154-63.

63. Walker JG, Anstey KJ, Lord SR. Psychological distress and visual functioningin relation to vision-related disability in older individuals with cataracts.British Journal of Health Psychology. 2006;11:303–317.

64. Matza LS, Rousculp MD, Malley K, Boye KS, Oglesby A. The longitudinallink between visual acuity and health-related quality of life in patients withdiabetic retinopathy. Health Qual Life Outcomes. 2008;6(1):95. Availablefrom : http://www.hqlo.com/content/6/1/95

65. Horowitz A. The prevalence and consequences of vision impairment in laterlife. Topics in Geriatric Rehabilitation. 2004;20:185–195.

66. Rowan HH. Visual problems and falls. Age and ageing. 2001;30(S4):13–18.67. Sugawara T, Hagiwara A, Hiramatsu A, Ogata K, Mitamura Y, Yamamoto S.

Relationship between peripheral visual field loss and vision-related quality oflife in patients with retinitis pigmentosa. Eye. 2009;24(4):535-9.

68. Van Senus AHC, Leber’s Disease in Netherland. Doc Ophtalmol.1963;17:1-163

69. Rothe NK, Sjolie AK, Jensen H, Borch-Johnsen K and Rosenberg T. Theprevalence and incidence of visual impairment in people of age 20-59 years inindustrialized countries: a review. 2003. Ophthalmic Epidemiology. 10 (4):279-291

70. Boerner K and Cimarolli VR. Optimizing rehabilitation for adults with visualimpairment: attention to life goals and their links to well-being. 2005. ClinicalRehabilitation.19 (7): 790-798.

71. Zhang X, Bullard K, Cotch M, et al. ASsociation between depression andfunctional vision loss in persons 20 years of age or older in the united states,nhanes 2005-2008. JAMA Ophthalmology. 2013;131(5):573-81. Availablefrom :

LAMPIRAN1. Ethical Clearance

2. Lembar Informed Consent

3.

SPSS Spreadsheet